San Diego, CA, United States of America

Pattraranee Limphong

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Pattraranee Limphong: Innovator in Therapeutic RNA Technologies

Introduction

Pattraranee Limphong is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of therapeutic RNA technologies, holding a total of 6 patents. His work focuses on innovative compositions and methods that address critical medical conditions.

Latest Patents

Among his latest patents, Limphong has developed compositions and methods for the treatment of ornithine transcarbamylase (OTC) deficiency. This patent describes compositions that include a lipid formulation and messenger RNA (mRNA) encoding an OTC enzyme. The lipid formulations can comprise an ionizable cationic lipid in a lipid nanoparticle encapsulating the mRNA. Another significant patent involves translatable molecules and the synthesis thereof. This patent outlines a range of therapeutic mRNA molecules that can express a target polypeptide or protein. The RNA molecules can contain one or more 5-methoxyuridines and 5-methylcytidines, and the processes for making these therapeutic mRNA molecules are also provided.

Career Highlights

Pattraranee Limphong is currently associated with Arcturus Therapeutics, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of various diseases and conditions.

Collaborations

Limphong collaborates with esteemed colleagues such as Kiyoshi Tachikawa and Padmanabh Chivukula, contributing to a dynamic research environment that fosters innovation.

Conclusion

Pattraranee Limphong's contributions to therapeutic RNA technologies exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to addressing critical health challenges through advanced scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…